A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether the use of warm or cold blood cardioplegia has superior myocardial protection. More than 192 papers were found using the reported search, of which 20 represented the best evidence to answer the clinical question. The authors, journal, date, country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. A good breadth of high-level evidence addressing this clinical dilemma is available, including a recent meta-analysis and multiple large randomized clinical trials. Yet despite this level of evidence, no clear significant clinical benefit has been demonstrated by warm or cold blood cardioplegia. This suggests that neither method is significantly superior and that both provide similar efficacy of myocardial protection. The meta-analysis, including 41 randomized control trials (5879 patients in total), concluded that although a lower cardiac enzyme release and improved postoperative cardiac index was demonstrated in the warm cardioplegia group, this benefit was not reflected in clinical outcomes, which were similar in both groups. This theme of benefit in biochemical markers, physiological metrics and non-fatal postoperative events in the warm cardioplegia group ran throughout the literature, in particular the 'Warm Heart investigators' who conducted a randomized trial of 1732 patients, demonstrated a reduction in postoperative low output syndrome (6.1 versus 9.3%, P = 0.01) in the warm cardioplegia group, but no significant drop in 30-day all-cause mortality (1.4 versus 2.5%, P = 0.12). However, their later follow-up indicates non-fatal postoperative events predict reduced late survival, independent of cardioplegia. A minority of studies suggested a benefit of cold cardioplegia over warm in particular patient subgroups: One group conducted a retrospective study of 520 patients who required prolonged aortic cross-clamp times, results demonstrated less myocardial damage and reduced postoperative cardiac mortality and morbidity in the cold group. The clinical bottom line is that warm and cold cardioplegia result in similar short-term mortality. However, large studies have shown that warm cardioplegia reduces adverse post-operative events; the significance of which is unclear.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] . Significantly lower in the warm blood cardioplegia group than in the tepid blood and cloud crystalloid groups at 12 h (0.8 ± 0.1, 1.9 ± 0.2 and 2.8 ± 0.3 ng/ml), respectively; P < 0.001. At 24 h, levels were (1.0 ± 0.1 ng/ml, 2.2 ± 0.3 ng/ml and 2.5 ± 0.3 ng/ml), respectively; P < 0.001)
THREE-PART QUESTION

Intubation and hospital stay
Lower in warm cardioplegia group Higher in the warm group (P < 0.02)
Continued
Inotropic support required to wean from CPB Less in the warm group compared with the cold group (P < 0.0001) provided the best evidence to answer the question. These are presented in Table 1 . Papers concerning: paediatric cardiothoracic surgery; retrograde cardioplegia; transplantation; and studies where multiple cardioplegia variables were changed, were excluded.
RESULTS
Fan et al. [2] conducted a meta-analysis of warm versus cold cardioplegia for cardiac surgery, using 41 randomized control trials (RCTs) totalling 5879 patients. Selection criteria were RCTs in adult patients, comparing warm (including lukewarm) with cold cardioplegia. Exclusions included transplant surgery and trials where patients received both cold and warm cardioplegia. Inhospital mortality was reported in 18 trials (4619 patients): 38 of 2307 patients died in the warm cardioplegia group and 49 of 2312 patients in the cold cardioplegia group. Analysis showed no significant differences between the groups for all-cause mortality (relative risk (RR) = 0.92, P = 0.49). Length of stay, rates of stroke, postoperative atrial fibrillation (AF) and IABP use were similar between the two groups. However, warm cardioplegia was associated with significantly better postoperative cardiac index (weighted mean difference (WMD) = 0.28, P < 0.00001) and lower cardiac troponin concentrations at day 0, and peak value (WMD = −0.61, P = 0.006; WMD = −1.45, P = 0.006, respectively). Also the peak cardiac-specific creatinine kinase (CK-MB) release was significantly less in the warm group (WMD = −8.03, P = 0.002). Subgroup analysis excluding cold crystalloid cardioplegia and lukewarm cardioplegia did not significantly alter the results.
Mallidi et al. [3] conducted a prospective cohort study of all isolated coronary bypass grafts at a single centre over 10 years comparing cold blood cardioplegia (1532) with warm or tepid blood cardioplegia (4532), on early and late outcomes. Allocation was random in 749 cases and according to surgeon preference in the remainder. Analysis revealed superior outcomes in the warm cardioplegia group: perioperative death (1.6 versus 2.5%, P = 0.027), myocardial infarction (2.4 versus 5.4%, P < 0.0001), death or myocardial infarction (3.8 versus 7.3%, P < 0.0001). Differences in survival at 60 months of warm versus cold cardioplegia groups (91.1 ± 1.4 versus 89.9 ± 1.3%, P < 0.09) and freedom from death or myocardial infarction (84.7 ± 1.8 versus 83.2 ± 1.6%, P < 0.16) was not statistically significant. In multivariate models, cold blood cardioplegia was associated with reduced survival (RR = 1.30, P < 0.09) and reduced freedom from any death or late myocardial infarction (RR = 1.93, P < 0.0001).
The Warm Heart Trial investigators [4] found that although enzymatic measurement of infarction was reduced in the warm group (12.3 versus 17.3%, P < 0.001), there was no difference in non-fatal Q-wave infarction. The warm group also suffered less from low output syndrome (6.1 versus 9.3%, P < 0.001), but there were no statistically significant differences in other clinical outcomes including 30-day all-cause mortality, stroke or reoperation for bleeding/tamponade. A sub-study by Christakis et al. [5] dividing patients into high, medium and low risk showed a significant reduction in mortality and morbidity overall (warm: 15.9 versus cold: 25.2%, P < 0.01) as defined by death and/or low output syndrome and/or enzymatic infarction, but the investigators were surprised not to find significant differences in the benefit of warm versus cold cardioplegia between groups.
Late survival results of the trial, published by Fremes et al. [6] , show that although there is non-significant benefit of warm over cold cardioplegia at 72 months (94.5 ± 1.7 versus 90.9 ± 2.6%, mean ± SEM), by 84 months survival was significantly reduced in those that experienced 'non-fatal peri-operative outcomes', such as low output syndrome (84.9 ± 4.5 versus 94.5 ± 1.7%, mean ± SEM; P < 0.001). The original trial data showed that these 'nonfatal perioperative outcomes' were significantly more prevalent among the cold group.
Tan et al. [7] compared cold (4°C; n = 951) to tepid (28°C; n = 582), rather than warm/normothermic, cardioplegia in a single surgeon practice, and found no significant difference in mortality, peri-operative MI, CVA or use of inotropes, despite the tepid group being reported as more high risk. They did, however, find significant reductions in the use of IABP and postoperative AF in the tepid group.
Liakopoulos et al. [8] identified high-risk patients undergoing cardiac surgery, defined as >75 min of aortic cross-clamping (520 of 3527). Although those patients who received cold cardioplegia (280/520) had statistically significant increases in postoperative stay, need for blood transfusion and intraoperative defibrillation, they ultimately found warm cardioplegia to be an independent predictor (P < 0.05) for 30-day all-cause mortality (odds ratio (OR)=2.42; 95% confidence interval (CI) 1.04-5.05), cardiac death (OR = 3.57; 95% CI 1.49-8.85), major adverse cardiac events (OR = 1.87; 95% CI 1.22-2.87) and perioperative myocardial injury (OR = 3.46; 95% CI 1.86-6.41). This was the only large study to find statistical significance in clinical outcomes in favour of cold cardioplegia, focusing on patients with extended cross-clamp times. These findings were supported by a small randomized trial of 35 patients undergoing aortic valve surgery [9] with hypertrophied left ventricles; results suggested that cold cardioplegia was associated with less ischaemic stress and myocardial injury.
CLINICAL BOTTOM LINE
Warm and cold cardioplegia result in similar short-term mortality. However, large studies have shown that warm cardioplegia reduces adverse postoperative events, the significance of which is unclear.
